Goldman Sachs
NVAX icon

Goldman Sachs’s Novavax NVAX Stock Holding History

Goldman Sachs’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.53M Hold
187,400
– – ﹤0.01% 4765
2025
Q4 		$1.26M Hold
187,400
– – ﹤0.01% 4954
2025
Q3 		$1.62M Hold
187,400
– – ﹤0.01% 4659
2025
Q2 		$1.18M Buy
+187,400
New +$1.24M ﹤0.01% 4572
2025
Q1 		– Sell
-58,800
Closed -$473K – 6314
2024
Q4 		$473K Buy
+58,800
New +$567K ﹤0.01% 5280
2022
Q1 		– Sell
-26,700
Closed -$3.82M – 6809
2021
Q4 		$3.82M Hold
26,700
– – ﹤0.01% 3679
2021
Q3 		$5.54M Hold
26,700
– – ﹤0.01% 3278
2021
Q2 		$5.67M Hold
26,700
– – ﹤0.01% 3223
2021
Q1 		$4.84M Buy
26,700
+1,000
+4% +$199K ﹤0.01% 3166
2020
Q4 		$2.87M Buy
25,700
+16,400
+176% +$1.74M ﹤0.01% 3454
2020
Q3 		$1.01M Buy
+9,300
New +$1.13M ﹤0.01% 4072
2020
Q2 		– Sell
-63,800
Closed -$866K – 5398
2020
Q1 		$866K Buy
+63,800
New +$540K ﹤0.01% 3853
2017
Q1 		– Sell
-6,750
Closed -$170K – 6924
2016
Q4 		$170K Sell
6,750
-3,000
-31% -$87.5K ﹤0.01% 5875
2016
Q3 		$406K Buy
9,750
+3,000
+44% +$387K ﹤0.01% 5233
2016
Q2 		$981K Hold
6,750
– – ﹤0.01% 4193
2016
Q1 		$697K Sell
6,750
-7,730
-53% -$829K ﹤0.01% 4410
2015
Q4 		$2.43M Hold
14,480
– – ﹤0.01% 3459
2015
Q3 		$2.05M Buy
+14,480
New +$3.25M ﹤0.01% 3769
2013
Q4 		– Sell
-10,000
Closed -$630K – 6753
2013
Q3 		$630K Buy
+10,000
New +$563K ﹤0.01% 4978

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs's NVAX Position: Q1 2026 in Review

Goldman Sachs increased its Novavax (NVAX) stake by 29% in Q1 2026, buying an estimated $2.89M and bringing the position to 1,409,446 shares worth $11.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2951.

Goldman Sachs first reported a position in NVAX in Q2 2013 and has held it in 52 quarters since. The position peaked at $139M in Q1 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Goldman Sachs held 1,409,446 shares of Novavax worth $11.5M as of Q1 2026.
  • Goldman Sachs bought 318,887 Novavax shares in Q1 2026, an estimated $2.89M.
  • Novavax made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2951 holding.
  • Goldman Sachs first reported a position in Novavax in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Novavax position peaked at $139M in Q1 2021.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.